Table of Contents
2021 - 2027 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications
1 Methodology and Data Source
1.1 Methodology/Research Approach
1.1.1 Research Programs/Design
1.1.2 Market Size Estimation
1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
1.2.1 Secondary Sources
1.2.2 Primary Sources
1.3 Disclaimer
2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Overview
2.1 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Overview
2.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Segment by Type
2.2.1 SGD - 2083
2.2.2 Crizanlizumab
2.2.3 PF - 04447943
2.2.4 NVX - 508
2.2.5 Others
2.3 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Segment by Type
2.3.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth (%) by Type ( 2016, 2020 and 2027)
2.3.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share (%) by Type ( 2016 - 2021)
2.3.3 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Market Share (%) by Type ( 2016 - 2021)
2.3.4 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Price (USD/Pcs) by Type ( 2016 - 2021)
2.4 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Segment by Type
2.4.1 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth by Type ( 2016, 2020 and 2027)
2.4.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Type ( 2016 - 2021)
2.4.3 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Market Share by Type ( 2016 - 2021)
2.4.4 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Price (USD/Pcs) by Type ( 2016 - 2021)
3 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Application/End Users
3.1 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Segment by Application/End Users
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Segment by Application
3.2.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and CGAR (%) by Application ( 2016, 2020 and 2027)
3.2.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share (%) by Application ( 2016 - 2021)
3.3 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Segment by Application
3.3.1 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and CGAR (%) by Application ( 2016, 2020 and 2027)
3.3.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share (%) by Application ( 2016 - 2021)
4 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size and CAGR by Regions ( 2016, 2020 and 2027)
4.1.2 North America
4.1.3 Asia - Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.1.7 United States
4.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales and Revenue by Regions
4.2.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share (%) by Regions ( 2016 - 2021)
4.2.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Market Share (%) by Regions ( 2016 - 2021)
4.2.3 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.4 North America Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.5 Europe Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.6 Asia - Pacific Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.7 South America Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ( 2016 - 2021)
4.2.8 Middle East and Africa Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
4.2.9 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin ( 2016 - 2021)
5 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Competition by Players/Manufacturers
5.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Players ( 2016 - 2021)
5.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Share by Players ( 2016 - 2021)
5.3 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Average Price (USD/Pcs) by Players ( 2016 - 2021)
5.4 Global Top Players Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Competitive Situation and Trends
5.5.1 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Concentration Rate
5.5.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share (%) of Top 3 and Top 5 Players
5.5.3 Mergers & Acquisitions, Expansion
6 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Competition by Players/Manufacturers
6.1 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Market Share by Players ( 2016 - 2021)
6.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Share by Players ( 2016 - 2021)
6.3 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Average Price (USD/Pcs) by Players ( 2016 - 2021)
6.4 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Share (%) of Top 3 and Top 5 Players
7 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Players/Manufacturers Profiles and Sales Data
7.1 AstraZeneca Plc
7.1.1 Company Basic Information, Manufacturing Base and Competitors
7.1.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca Plc Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Bristol - Myers Squibb Company
7.2.1 Company Basic Information, Manufacturing Base and Competitors
7.2.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol - Myers Squibb Company Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Gilead Sciences Inc
7.3.1 Company Basic Information, Manufacturing Base and Competitors
7.3.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Gilead Sciences Inc Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Modus Therapeutics Holding AB
7.4.1 Company Basic Information, Manufacturing Base and Competitors
7.4.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Modus Therapeutics Holding AB Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Novartis AG
7.5.1 Company Basic Information, Manufacturing Base and Competitors
7.5.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Novartis AG Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.5.4 Main Business/Business Overview
7.6 NuvOx Pharma LLC
7.6.1 Company Basic Information, Manufacturing Base and Competitors
7.6.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 NuvOx Pharma LLC Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Pfizer Inc
7.7.1 Company Basic Information, Manufacturing Base and Competitors
7.7.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Pfizer Inc Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Seattle Genetics Inc
7.8.1 Company Basic Information, Manufacturing Base and Competitors
7.8.2 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Seattle Genetics Inc Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)( 2016 - 2021)
7.8.4 Main Business/Business Overview
8 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Manufacturing Cost, Industrial Chain and Downstream Buyers
8.1 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States
9 Marketing Strategy Analysis, Distributors and Market Effect Factors
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
9.3.1 Economic/Political Environmental Change
9.3.2 Downstream Demand Change
9.3.3 Technology Progress in Related Industry
9.3.4 Substitutes Threat
10 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast
10.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales, Revenue Forecast ( 2021 - 2027)
10.1.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Forecast ( 2021 - 2027)
10.1.2 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (%) Forecast ( 2021 - 2027)
10.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Market Forecast
10.2.1 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Forecast ( 2021 - 2027)
10.2.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) and Growth Rate (%) Forecast ( 2021 - 2027)
10.3 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Forecast by Regions
10.3.1 North America Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.2 Europe Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.3 Asia - Pacific Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.4 South America Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.3.5 Middle East and Africa Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast ( 2021 - 2027)
10.4 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Forecast by Type
10.4.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type ( 2021 - 2027)
10.4.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type ( 2021 - 2027)
10.5 Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Forecast by Application
10.5.1 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application ( 2021 - 2027)
10.5.2 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) Forecast by Application ( 2021 - 2027)
11 Research Findings and Conclusion
List of Tables and Figures
Table Research Programs/Design for This Report
Figure Bottom - up and Top - down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Product Picture
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Product Picture of SGD - 2083
Table Major Players of SGD - 2083
Figure Global SGD - 2083 Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Crizanlizumab
Table Major Players of Crizanlizumab
Figure Global Crizanlizumab Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of PF - 04447943
Table Major Players of PF - 04447943
Figure Global PF - 04447943 Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of NVX - 508
Table Major Players of NVX - 508
Figure Global NVX - 508 Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)( 2016 - 2021)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type ( 2016, 2020 and 2027)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) by Type ( 2016 - 2021)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share (%) by Type ( 2016 - 2021)
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Type ( 2016 - 2021)
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Type in 2020
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) by Type ( 2016 - 2021)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Share (%) by Type ( 2016 - 2021)
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Share (%) by Type ( 2016 - 2021)
Figure 2020 Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share (%) by Type
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Price (USD/Pcs) by Type ( 2016 - 2021)
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type ( 2016, 2020 and 2027)
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) by Type ( 2016 - 2021)
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share (%) by Type ( 2016 - 2021)
Figure United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Type ( 2016 - 2021)
Figure United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Type in 2020
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue (Million USD) by Type ( 2016 - 2021)
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Share (%) by Type ( 2016 - 2021)
Figure United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Share (%)by Type ( 2016 - 2021)
Figure 2020 United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Revenue Market Share (%) by Type
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Price (USD/Pcs) by Type ( 2016 - 2021)
Figure Clinic Examples
Figure Hospital Examples
Figure Others Examples
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) Comparison by Application ( 2016 - 2027)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) by Application ( 2016 - 2021)
Table Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Share (%) by Application ( 2016 - 2021)
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Application ( 2016 - 2021)
Figure Global Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales Market Share (%) by Application in 2020
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) Comparison by Application ( 2016 - 2027)
Table United States Vaso - Occlusive Crisis Associated With Sickle Cell Disease Drug Sales (K Pcs) by Application ( 2016 - 2021)
Table United States Vaso - Occlusive Crisis Assoc
